Q3 2017 Holdings
Filed 2017-11-09 | 14 holdings | $11.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adma Biologics Inc(ADMA) | COM | 000899104 | $11.1M | 3,608,171 | 94.9% |
| Loxo Oncology Inc | COM | 548862101 | $385.9K | 4,188,920 | 3.3% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $74.1K | 2,990,000 | 0.6% |
| Viewray Inc(VRAYQ) | COM | 92672L107 | $43.1K | 7,480,887 | 0.4% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $42.0K | 837,125 | 0.4% |
| Transenterix Inc | COM NEW | 89366M201 | $14.8K | 10,335,819 | 0.1% |
| Entellus MED Inc | COM | 29363K105 | $9.8K | 528,655 | 0.1% |
| Cidara Therapeutics Inc | COM | 171757107 | $8.3K | 1,021,148 | 0.1% |
| Agile Therapeutics Inc(AGRXUSD) | COM | 00847L100 | $8.1K | 1,804,933 | 0.1% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $7.5K | 508,565 | 0.1% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $2.5K | 472,943 | 0.0% |
| Pernix Therapeutics Hldgs Inc | DBCV 4.250% 4/0 | 71426VAK4 | $1.1K | $2,500,000 | 0.0% |
| Pernix Therapeutics Hldgs Inc | COM NEW | 71426V306 | $662 | 210,000 | 0.0% |
| Zeltiq Aesthetics Inc | COM | 98933Q108 | $0 | 11,985 | 0.0% |